Pharmacotherapy for human immunodeficiency virus-associated nephropathy. (Q36320626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Pharmacotherapy for human immunodeficiency virus-associated nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Scott D Pope

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D Byron May

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1761-1772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

The nephropathies of HIV infection: pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIV-associated nephropathy: case study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

The epidemiology of end-stage renal disease among African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Predictors of proteinuria and renal failure among women with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Focal segmental glomerulosclerosis in African Americans: effects of steroids and angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Racial and socioeconomic factors in glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

A 20-year history of childhood HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Course and prognosis of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Renal involvement in patients infected with HIV: experience at San Francisco General Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Captopril and renal survival in patients with human immunodeficiency virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Protease inhibitors modulate apoptosis in mesangial cells derived from a mouse model of HIVAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Zidovudine is beneficial in human immunodeficiency virus associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

HIV-associated nephropathy: a review of the epidemiology and clinical course in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Asymptomatic HIV patient with cardiomyopathy and nephropathy: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Diagnosis and treatment of HIV-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Human Immunodeficiency Virus Infection in End‐Stage Renal Disease Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

An appraisal of antiretroviral drugs in hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Nephrotic syndrome associated with acquired immunodeficiency syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

A steroid-responsive nephrotic syndrome in a patient with human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.12.1761

10.1592/PHCO.2005.25.12.1761

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16305296%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference